InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,973.60
(
0.40%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.18
(
-0.28%
)
Bitcoin
57,364.62
(
1.16%
)
Post# of 252526
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 132041

Monday, 04/02/2012 3:23:43 PM

Monday, April 02, 2012 3:23:43 PM

Post# of 252526
The first three Novartis QVA149 Phase III studies for approval in the EU and Japan in the treatment of COPD met their primary endpoints:

http://www.novartis.com/newsroom/media-releases/en/2012/1599186.shtml
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up